The issue opened for bidding on Friday (07 November 2025) and it will close on Tuesday (11 November 2025). The price band of the IPO is fixed between Rs 120 to Rs 128 per share. The minimum order quantity is 1,000 equity shares. The equity shares will list on NSE's SME platform.
The IPO comprises fresh issue of 21,50,000 equity shares. The promoter and promoter group shareholding will dilute to 68.03% from 92.68% pre-issue.
About 1,08,000 equity shares will be reserved for subscription by market maker to the issue. The net issue comprises of 20,42,000 equity shares. The issue and net issue will constitute 26.59% and 25.26% respectively of the post- issue paid-up equity share capital of the company.
The company intends to utilize the net proceeds for capital expenditure towards upgradation/improvement of the existing manufacturing facilities, capital expenditure towards construction of a storage facility, pre-payment/repayment of outstanding secured loans, product registrations in other countries, funding the working capital requirements and general corporate purposes.
Ahead of the IPO, Curis Lifesciences on 06 November 2025, raised Rs 7.79 crore from anchor investors. The board allotted 6.09 lakh shares at Rs 128 per share to 6 anchor investors.
Curis Lifesciences is the pharma manufacturer, specializing in manufacturing of a wide range of pharmaceutical products such as tablets, capsules, external preparations, oral liquid, sterile ophthalmic ointments. It operates in global as well as domestic markets. It undertakes manufacturing activities on loan license, contract manufacturing and direct export basis/own brand marketing basis. As of 31 July 2025, the company had 95 permanent employees.
The company recorded revenue from operations of Rs 2.87 crore and net profit of Rs 19.50 crore for the period ended 31 July 2025.
Powered by Capital Market - Live News
Beware of fraudulent tips, unauthenticated news and advice on stock market.
At BOB Capital, your account security is our topmost priority. Beware of receiving fraudulent communications, unauthenticated trading tips and unsolicited calls on trading in stocks from unverified sources, received through Whatsapp, Telegram, SMS, Calls, etc and take an informed decision before investing.
What should you do if you receive a trading tip over phone or SMS?
Report unsolicited messages to the Stock Exchange on +91 8291833676 or on designated email id i.e. feedbk_invg@nse.co.in. Please visit here to understand better.
Please visit CVC website at pledge.cvc.nic.in and take "Integrity Pledge" to be an active part of the "Satark Bharat, Samriddh Bharat" (Vigilant India, Prosperous India).
Filing complaints on SCORES - Easy & quick: a. Register on SCORES portal scores.sebi.gov.in/ b. Mandatory details for filing complaints on SCORES are i. Name, PAN, Address, Mobile Number, E-mail ID. c. Benefits: i. Effective communication ii. Speedy redressal of the grievances.
Valued Customer,
BOB Capital Markets Limited (BOBCaps) is firmly committed to the safety of your wealth. We would like to bring to your notice certain precautions that you certainly must take against potential tele-fraudsters/ unscrupulous and unregistered portfolio managers:
ALWAYS AVOID
We would like to caution you against such fraudulent calls and SMSes and urge you to be alert. Follow the golden rule:
Do not share your Login Credentials or Passwords with anybody
BOBCaps employees / representatives never ask for your password.
Certain tele-fraudsters / unscrupulous and unregistered portfolio managers call customers or SMS them on the pretext of providing investment tips and lure them to invest through their bogus firms by promising huge profits.
Such deceitful callers ask the customer to share his/her login credentials with passwords to allow trading in their accounts, assuring huge returns.
Often trades done in the customer’s accounts are far from the best interest of the customers. Holdings of customers are often sold and with the funds, trades are then placed in illiquid securities at unrealistic prices.
At times, the holdings of customers are sold at prices detrimental to the customer. The so-called “portfolio manager” assures profits, which naturally does not materialize. Customers are deceived into providing access to their trading accounts, thereby allowing such fraudsters access to funds and securities available to execute trades, injurious to the customer’s interest.
In our continuous effort to keep you safeguard from the market related frauds and increase awareness while conducting trades, we request you to go through the Press Release issued by the NSE and would request you to ensure that you do not engage with the individuals and entities mentioned below: